Expert Exchange: How to Formulate the Relationship Between the Ob/Gyn and the Interventional Radiologist for the Treatment of Uterine Fibroids
Benign uterine fibroids are the most common types of tumor in a woman?s pelvis. According to the American College of Obstetricians and Gynecologists (ACOG), these fibroids occur in approximately 25% to 50% of all women, with the highest incidence reported in women aged 30 to 40 years. Most fibroids are so small and asymptomatic that women are unaware of their presence. Even large fibroids may not cause bothersome symptoms, although they commonly are found in women who have menorrhagia (heavy periods), frequent urination, pelvic pain, back pain, infertility, and/or pregnancy loss.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
